Evidence map›Paper›PMID 39479482›Full record

ArticleRSC advances2024

Martyna Nikody, Lilian Kessels, Lizette Morejón, Matthias Schumacher, Tim G A M Wolfs, Timo Rademakers, José A Delgado, Pamela Habibovic, Lorenzo Moroni, Elizabeth R Balmayor

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Martyna NikodyComplex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University 6229 ER Maastricht The Netherlands.ORCID https://orcid.org/0000-0001-5226-0902
Lilian KesselsDepartment of Paediatrics, Research Institute for Oncology and Reproduction (GROW), Maastricht University Maastricht The Netherlands.
Lizette MorejónCenter of Biomaterials, University of Havana 10400 Havana Cuba.
Matthias SchumacherDepartment of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University Maastricht The Netherlands.
Tim G A M WolfsDepartment of Paediatrics, Research Institute for Oncology and Reproduction (GROW), Maastricht University Maastricht The Netherlands.
Timo RademakersComplex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University 6229 ER Maastricht The Netherlands.ORCID https://orcid.org/0000-0003-0286-418X
José A DelgadoCenter of Biomaterials, University of Havana 10400 Havana Cuba.
Pamela HabibovicDepartment of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University Maastricht The Netherlands.ORCID https://orcid.org/0000-0001-8249-5155
Lorenzo MoroniComplex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University 6229 ER Maastricht The Netherlands.ORCID https://orcid.org/0000-0003-1298-6025
Elizabeth R BalmayorCell Biology-Inspired Tissue Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University 6229 ER Maastricht The Netherlands.ORCID https://orcid.org/0000-0002-0484-4847

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioactive glasses (BGs) belong to a group of ceramic biomaterials having numerous applications due to their excellent biocompatibility and bioactivity. Depending on their composition, properties of BGs can be finely tuned. In this study, we investigated both angiogenic and osteogenic properties of a novel family of BGs from the SiO

Identifiers

PMID39479482
PMCPMC11523078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.